Research Article
Validation Protocol of Vitamin D Supplementation in Patients with HIV-Infection
Table 2
Patients with vitamin D < 10 ng/mL at baseline. Objective vitamin D > 20 ng/mL. Univariate and multivariate analysis.
| | Univariate analysis | Multivariate analysis | | Objective yes: 69 (82.1%) (%) | Objective no: 15 (17.9%) (%) | | OR (95% CI) | |
| VitD supplements | | | | | | Yes | 60 (96.8) | 2 (3.2) | 0.0001 | 66.76 (10.06–442.85) | 0.0001 | No | 9 (40.9) | 13 (59.1) | | | |
| TDF exposure | | | | 0.33 (0.05–1.92) | 0.22 | Yes | 32 (84.2) | 6 (15.8) | 0.65 | | | No | 37 (80.4) | 9 (19.6) | | | |
| NNRTI exposure | | | | 1.12 (0.69–18.38) | 0.93 | Yes | 26 (76.5) | 8 (23.5) | 0.26 | | | No | 43 (86) | 7 (14) | | | |
| PIs exposure | | | | 0.19 (0.01–2.97) | 0.23 | Yes | 42 (89.4) | 5 (10.6) | 0.08 | | | No | 27 (73) | 10 (27) | | | |
|
|